SK bioscience to acquire German biotech firm IDT Biologika
SK bioscience Co., a biopharmaceutical arm of South Korea’s SK Group, said Thursday it has agreed to pay 339 billion won (US$243 million) for control of German biotech company IDT Biologika.
The acquisition of IDT Biologika will give SK bioscience a …